Saeed Ahmed Memon: Can Hydralazine Stop Aggressive Brain Cancer Cells?
Saeed Ahmed Memon, Psychiatrist at Health Department Govt of SINDH Pakistan, shared a post on LinkedIn:
“Medical researchers at the University of Pennsylvania have recently unlocked the precise molecular secrets of Hydralazine, a cardiovascular medication that has been utilized globally for decades.
Scientists discovered that this established drug fundamentally works by blocking a specific oxygen-sensing enzyme known as ADO, which typically signals blood vessels to severely constrict when oxygen levels drop.
By actively shutting down this specific enzyme, the medication stabilizes cellular proteins and forces blood vessels to relax.
However, while mapping this exact cardiovascular mechanism, researchers stumbled upon an incredible secondary application regarding one of the most notoriously aggressive forms of brain cancer.
The exact oxygen-sensing pathway that constricts blood vessels is identically utilized by Glioblastoma tumors to survive and thrive in low-oxygen environments.
When scientists applied Hydralazine to these malignant cells, the medication did not kill them directly, but instead trapped the cancer in a dormant, non-dividing state known as senescence, abruptly halting the tumor’s growth.
This remarkable scientific breakthrough highlights the massive, untapped potential of repurposing established, safety-tested pharmaceutical compounds to combat highly complex oncological challenges.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 21:47Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention
-
Sep 29, 2026, 22:26A Global Call for Action on Cardiovascular Health on World Heart Day – ISTH